Cited by — Bimekizumab Long-Term Safety and Efficacy Across the Spectrum of Axial Spondyloarthritis Over 3 Years: Results From 2 Phase III Studies | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite Bimekizumab Long-Term Safety and Efficacy Across the Spectrum of Axial Spondyloarthritis Over 3 Years: Results From 2 Phase III Studies.
No admitted local citation edges point to this work yet.
